沙利度胺用于治疗消化道疾病的研究
摘要
目的 :介绍沙利度胺治疗消化道疾病的临床新进展。方法 :参阅文献 ,归纳 ,分析。结果 :由于沙利度胺的免疫调节和血管生成抑制作用 ,可以用于一系列免疫功能异常的消化道疾病。结论 :如何合理使用沙利度胺治疗消化道疾病 ,是值得探讨的问题。
出处
《中国医院药学杂志》
CAS
CSCD
北大核心
2004年第10期635-637,共3页
Chinese Journal of Hospital Pharmacy
参考文献21
-
1Richardson P, Hideshima T, Anderson K. Thalidomide: emerging role in cancer medicine[J]. Ann Rev Med,2002,53(4) :629.
-
2Eriksson T, Bjorkman S, Hoglund P. Clinical pharmacology of thalidomide[ J ]. Eur J Clin Pharmacol, 2001,57 (5): 365.
-
3Gunzler V. Thalidomide in human immunodeficiency virus (HIV)patients. A review of safety considerations[J]. Drug Saf, 1992,7(2):116.
-
4Chen TL, Vogelsang GB, Petty BG, et al. Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers[J ]. Drug Metab Dispos, 1989,17(4): 402.
-
5Piscitelli SC,Figg WD,Hahn B,et al. Single- dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients[ J ]. Antimicrob Agents Chemother, 1997,41 (12): 2797.
-
6Teo SK, Harden JL, Burke AB, et al. Thalidomide is distributed into human semen after oral dosing[J]. Drug Metab Dispos,2001,29(10): 1355.
-
7cheffler MR, Colbum W, Kook KA, et al. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics[J]. Clin Pharmacol Ther, 1999,65 (5): 483.
-
8Parker PM, Chao N, Nademanee A, et al. Thalidomide as salvage therapy for chronic graft-versus-host disease [ J ]. Blood, 1995,86(9):3604.
-
9Lopez J, Ulibarrena C, Garcia-Larana J, et al. Thalidomide as therapy for intestinal chronic GVHD [ J ]. Bone Marrow Transplant, 1993,11(3) :251.
-
10Jacobson JM, Greenspan JS, Spritzler J, et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National institute of allergy and infectious diseases AIDS clinical trials group[J ]. N Engl J Me
-
1周龙书,李李,史文静.Vasohibin-1、VEGF在子宫内膜腺癌中的表达及意义[J].中国妇幼保健,2015,30(3):350-352. 被引量:8
-
2韩峻松,田培坤,顾健人.抑制肿瘤血管生成治疗肿瘤的研究进展[J].国外医学(肿瘤学分册),2000,27(2):94-96. 被引量:4
-
3王成伟,庞琦,张庆林.血管生成与肿瘤的生长及转移[J].国外医学(肿瘤学分册),2001,28(2):118-120. 被引量:10
-
4马海清,许林锋.姜黄素抗血管生成作用及在肝癌介入治疗中的应用前景[J].国外医学(临床放射学分册),2006,29(6):412-415. 被引量:2
-
5魏子白.色素内镜诊断与治疗食管癌的临床新进展[J].中华腹部疾病杂志,2002,2(1):70-72. 被引量:4
-
6焦小龙.肺癌临床新进展——第八届国际肺癌大会概述[J].国外医学(肿瘤学分册),1998,25(3):152-156. 被引量:10
-
7刘文稚(综述),王小燕(综述),李孟考(综述),李丽(审校).乳腺癌抗血管治疗药物研究进展[J].国际肿瘤学杂志,2010,37(6):442-444.
-
8孙振华,陈平.中药及血管生成抑制因子治疗肿瘤的研究现状与展望[J].黑龙江医学,2006,30(3):192-194. 被引量:6
-
9付彦超,张庆瑜.胃癌血管生成及抗血管生成治疗的研究进展[J].世界华人消化杂志,2008,16(18):2012-2018. 被引量:4
-
10董宏伟,何三光,张伟.大肠癌形成过程中肿瘤血管生成肿瘤细胞增殖及凋亡的变化[J].中国实用外科杂志,2003,23(7):424-426.